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Abstract Embryonic stem (ES) cells are pluripotent cells with
the potential capacity to generate any type of cell. We describe
here the isolation of pluripotent ES-like cells from equine blas-
tocysts that have been frozen and thawed. Our two lines of ES-
like cells (E-1 and E-2) appear to maintain a normal diploid
karyotype inde¢nitely in culture in vitro and to express markers
that are characteristic of ES cells from mice, namely, alkaline
phosphatase, stage-speci¢c embryonic antigen-1, STAT-3 and
Oct 4. After culture of equine ES-like cells in vitro for more
than 17 passages, some ES-like cells di¡erentiated to neural
precursor cells in the presence of basic ¢broblast growth factor
(bFGF), epidermal growth factor and platelet-derived growth
factor. We also developed a protocol that resulted in the di¡er-
entiation of ES-like cells in vitro to hematopoietic and endothe-
lial cell lineages in response to bFGF, stem cell factor and
oncostatin M. Our observations set the stage for future develop-
ments that may allow the use of equine ES-like cells for the
treatment of neurological and hematopoietic disorders.
/ 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
One of the goals of animal biotechnology is the application
of current techniques of genetic engineering to the production
of farm animals with desired traits. At present, foreign genes
can be introduced into the murine genome via embryonic stem
(ES) cells and the use of homologous recombination tech-
niques [1]. In this system, cultured murine ES cells can be
used as a tool for the addition or deletion of genes at speci¢c
sites in the genome. Moreover, ES cells have the stable devel-
opmental capacity to form derivatives of all three layers of
embryonic germ cells, and successful di¡erentiation in vitro to
neurons, hematopoietic cells and cardiac muscle has been re-
ported [2^4].
The isolation of pluripotent lines of human ES cells from
blastocysts has also been reported [5,6]. ES cells have been
used as inde¢nite donor cells for the production of transgenic
clonal o¡spring [7^9]. In view of the probable signi¢cant con-
tribution of ES cells to e¡orts to manipulate the genome, to
generate transgenic clonal o¡spring, and to replace various
tissues and organs, it appears appropriate to attempt to adapt
this technology to the genetic improvement of farm animals.
With respect to species other than mice and man, sheep [10],
pig [10], rabbit [11], bovine [12,13], mink [14], hamster [15], rat
[16], and monkey [17] have all been reported as sources of
putative ES cells. However, neither production of chimeric
animals with traits that are transmitted through the germ
line nor satisfactory demonstration of the essential traits of
‘ES cells’ has yet been reported.
The method used for the isolation of murine ES cells [18]
has been adapted to other species with some modi¢cations.
However, attempts at the primary culture of cells of the inner
cell mass (ICM) of various species on a feeder layer of em-
bryo-derived mouse STO cells or a primary culture of mouse
embryonic ¢broblasts in the presence of leukemia inhibitory
factor (LIF) have seldom been successful. A combination of
growth factors might be required for the proliferation of these
pluripotent cells, as has been demonstrated in the case of
cultures of mouse primordial germ cells [19]. Among studies
of domestic animals, investigations of the development in vi-
tro of equine embryos at the preimplantation stage have been
quite limited [20^22]. Isolation of equine ES cells would put
horses in the front lines of animal biotechnology and the
modi¢cation of animal genomes.
We report here the successful isolation of immortalized
equine ES-like cells with a normal karyotype from frozen
and thawed blastocysts that were cultured on a feeder layer
derived from bovine umbilical ¢broblasts. These cells exhib-
ited some of the essential features of ES cells, expressing the
transcription factor STAT-3 [23], Oct 4 [24], the cell surface
marker known as stage-speci¢c embryonic antigen-1 (SSEA-1)
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[25], and alkaline phosphatase [26]. We con¢rmed the capacity
of these ES-like cells for somatic di¡erentiation in vitro to
neural progenitor cells and to endothelial or hematopoietic
lineages.
2. Materials and methods
2.1. Recovery of equine blastocysts and freezing and thawing for
subsequent propagation of cells
We used four Hokkaido native ponies as the source of embryos. We
£ushed their uteri 26 times in all and, as a result, we obtained a total
of 14 blastocysts on 6^7 days after natural ovulation as described
elsewhere [27,28]. After washing in Dulbecco’s phosphate-bu¡ered sa-
line (DPBS; Sigma, St. Louis, MO, USA) supplemented with 10%
fetal bovine serum (FBS; Invitrogen, Groningen, The Netherlands),
blastocysts were equilibrated for 10 min in a 10% (v/v) solution of
glycerol in DPBS supplemented with 20% newborn calf serum (Mit-
subishi-Kasei, Tokyo, Japan). The blastocysts were then put into in-
dividual plastic straws (0.25 ml). Each straw was held for 15 min at
35‡C and then cooled to 330‡C at a rate of 0.5‡C/min in a program-
mable freezer. Finally, straws were plunged into liquid nitrogen and
stored for up to 1 year prior to use. Blastocysts were thawed by
immersion of straws for 20 s in a water bath at 37‡C. Then blastocysts
were incubated with DPBS plus 10% FBS that contained 6% glycerol
and 0.3 M sucrose for 5 min, and with DPBS plus 10% FBS that
contained 3% glycerol and 0.3 M sucrose for another 5 min, with
DPBS plus 10% FBS that contained 0.3 M sucrose for 5 min and
then, ¢nally, they were washed with DPBS plus 10% FBS. These
blastocysts were used for microsurgical dissection of the ICM.
2.2. Preparation of a feeder layer
Biopsy samples of bovine umbilical cord were collected from a
newborn calf and washed thoroughly in PBS (Sigma) supplemented
with penicillin (100 IU/ml) and streptomycin (50 Wg/ml), to remove
toxic agents and possible contaminants. Samples were cut into small
pieces of approximately 1^4 mm3 with ¢ne scalpel blades in a sterile
dish. Several of these small pieces of tissue were placed in a tissue
culture dish (diameter 6 cm) and cultured in K-minimum essential
medium (KMEM; Life Technologies, Rockville, MD, USA), supple-
mented with 10% FBS, penicillin (100 IU/ml) and streptomycin (50
Wg/ml), in a humidi¢ed atmosphere of 5% CO2 in air at 38.6‡C. Um-
bilical cord-derived ¢broblasts grew to con£uence and were then sub-
cultured two or three times before use as a feeder layer.
2.3. Isolation and proliferation of ES cells
Three ICMs were isolated microsurgically from three morphologi-
cally intact, frozen and thawed equine blastocysts. They were placed
in KMEM supplemented with 10% FBS, 0.1 mM 2-mercaptoethanol
(2-ME), human LIF (10 ng/ml; Sigma), penicillin (100 IU/ml) and
streptomycin (50 Wg/ml) with a feeder layer of mitotically inactivated
umbilical cord-derived ¢broblasts in four-well culture plates (Nalge
Nunc International, Roskilde, Denmark) in a humidi¢ed atmosphere
of 5% CO2 in air at 38.6‡C. After 3^5 days, growing colonies whose
morphology was typical of ES cells were dispersed by brief treatment
with a mixture of 0.25% trypsin^EDTA (Life Technologies). The re-
sultant dissociated cells were replated on a fresh feeder layer and
cultured under the same conditions as described above. After 10^14
days, cells with ES-like morphology [25] that had become con£uent
were picked up and replated on a fresh feeder layer (passage 1 or P1
cells). P1 cells were then subjected to repeated passages at 6- to 7-day
intervals. Cultures were examined daily and medium was replaced
every second day.
In some experiments, colonies of cells were transferred to standard
culture medium (KMEM supplemented with 10% FBS, 0.1 mM 2-ME,
penicillin and streptomycin) plus human LIF (10 ng/ml) in culture
plates for induction of di¡erentiation or to standard culture medium
without LIF for induction of the formation of embryoid bodies (EBs)
in the absence of a feeder layer. Karyotype analysis (Giemsa staining)
was performed as described previously [10,29].
2.4. Characterization of stem cells
For analysis of the expression of SSEA-1, we plated equine ES cells
at 2U105 cells per well in four-well dishes and cultured them for
5 days in standard medium with LIF. Then cells were harvested
and incubated with horse immunoglobulin (IgG; Sigma) and mouse
monoclonal antibodies against mouse SSEA-1 (IgM; Kyowa Medex,
Tokyo, Japan) and subsequently with £uorescein isothiocyanate-con-
jugated (FITC-conjugated) second antibodies raised in rabbit against
mouse IgM or IgG (Fujisama Pharmacia, Tokyo, Japan). Expression
of SSEA-1 was examined by £ow cytometry in a cell sorter (FACS-
can; Becton-Dickinson, Mountain View, CA, USA).
To evaluate the expression of STAT-3, we plated frozen and thawed
equine ES cells (P17) at 1U104 cells per well in four-well dishes with-
out a feeder layer and cultured them in the presence of LIF for 4 days
in standard medium. Cells were ¢xed in 4% paraformaldehyde and
immunostained with mouse STAT3-speci¢c antibody (10 Wg/ml; Sig-
ma) and with FITC-conjugated rabbit antibodies against mouse IgG
as second antibodies (1:100; Sigma). Images were obtained by £uo-
rescence microscopy (TE300; Nikon, Tokyo, Japan). Alkaline phos-
phatase activity was examined as described previously [26].
2.5. Di¡erentiation to neural precursor cells in vitro
To initiate di¡erentiation, we cultured dissociated ES cells (P18) at
1U104 cells per well in serum-free standard medium with mouse basic
¢broblast growth factor (bFGF, 10 ng/ml; Sigma), mouse epidermal
growth factor (EGF, 10 ng/ml; Sigma) and mouse platelet-derived
growth factor (PDGF, 10 ng/ml; Sigma) for 7 days [2,30]. Then we
analyzed cells for the expression of nestin using a mouse nestin-spe-
ci¢c antibody (Chemicon International, Temecula, CA, USA) and
FITC-conjugated rabbit antibodies against mouse IgG as second anti-
bodies (Jackson Laboratories, West Grove, PA, USA). Upon removal
of growth factors, cells were allowed to undergo di¡erentiation for
7^14 days. Di¡erentiated cells were examined for immunoreactivity
with antibodies against an astrocyte-speci¢c marker, mouse glial ¢-
brillary acidic protein (GFAP; Sigma), and against a neuron-speci¢c
marker, mouse L-tubulin III (Sigma). Cells were ¢xed and analyzed as
described above.
2.6. Di¡erentiation in vitro to hematopoietic and endothelial precursor
cells
Dissociated ES cells (P18) were cultured at 1U104 cells per well in
standard medium with 10% FBS, stem cell factor (SCF, 10 ng/ml;
Sigma), bFGF (10 ng/ml; Sigma) and oncostatin M (OSM, 10 ng/
ml; Sigma). After 10 days, cobblestone-like and endothelial-like cells
were examined for immunoreactivity with an antibody against a
marker of hematopoietic progenitor cells (mouse CD45; Sigma) and
FITC-conjugated second antibody (PharMingen, San Diego, CA,
USA).
Endothelial-like cells were cultured for an additional 7^10 days in
medium without growth factors. These cells were then analyzed for
the expression of markers of endothelial precursor cells with antibod-
ies against mouse CD31, CD34 and fetal liver kinase-1 (Flk-1) (all
purchased from Sigma) and FITC-conjugated rabbit antibodies
against mouse IgG as second antibodies (PharMingen). Cells were
¢xed and analyzed for the expression of each marker as described
above.
2.7. Reverse transcription-polymerase chain reaction (RT-PCR) and
analysis by PCR of the expression of marker genes
Total RNA (10 Wg) was isolated from ES cells with Trizol-Ls re-
agent (Invitrogen), and SuperScript II (Invitrogen) reverse transcrip-
tase was used to synthesize cDNA according to the protocol from
Invitrogen. Genomic DNA was prepared by the standard method as
described elsewhere [29]. The reaction mixture for PCR contained
cDNA (equivalent to 25 Wg of total RNA) or genomic DNA
(0.5 Wg), speci¢c primers (5 pmol each), 50 mM dNTPs, 1Ubu¡er
for KOD Dash and 0.5 U of KOD Dash polymerase (Toyobo, Osaka,
Japan). Each thermal cycle for ampli¢cation included incubation at
94‡C for 15 s, at 55‡C for 30 s and at 72‡C for 2 min. The cycle
was repeated 40 times with ¢nal extension for 10 min at 72‡C. Primers
speci¢c for SRY DNA [combination 1, sense 5P-gCCATTCTTCg-
AggAggCACAgA-3P (nt 402^425) and antisense 5P-TATCgACCTCg-
TCggAAggC-3P (nt 466^486)] and [combination 2, sense 5P-TggTgT-
ggTCTCgTgATCAggCgCAAgg-3P (nt 284^314) and antisense 5P-
TCTgTgCCTCCTCgAAgAATggC-3P (nt 402^425)], for Oct 4 mRNA
[sense 5P-TCCCAggACATCAAAgCTCTgCAgA-3P (nt 848^873) and
antisense 5P-TCTgggCTCTCCCATgCATTCAAACTgA-3P (nt 1495^
1524)], for STAT-3 mRNA [sense, 5P-TCTggCTAgACAATATCATC-
gACCTTg-3P (nt 1908^1935) and antisense 5P-TTATTTCCAAACTG-
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CATCAATgAATCT-3P (nt 2413^2439)], for GFAP mRNA [sense 5P-
gCCCTggACATCgAgATCgCCACCTACAgg-3P (nt 1091^1120) and
antisense 5P-ATgTTCCTCTTgAggTggCCTTCTgACAC-3P (nt 1214^
1244)], for L-tubulin III mRNA [sense 5P-CAgAgCAAgAACAg-
CAgCTACTT-3P (nt 999^1022) and antisense 5P-gTgAACTCCA-
TCTCgTCCATgCCCTC-3P (nt 1201^1227)], for GATA-4 mRNA
[sense 5P-CTCTggAggCgAgATgggACggg-3P (nt 971^994) and anti-
sense 5P-gAgCggTCATgTAgAggCCggCAggCATT-3P (nt 1452^1481)],
for Flk-1 mRNA [sense 5P-CTgCCTACCTCACCTgTTTCCTgTA-
Tgg-3P (nt 3833^3861); and antisense 5P-ggATATCTTgAAATgT-
TTTTACACTCAC-3P (nt 4003^4031)], and for GAPDH mRNA
[sense 5P-gggCTTggCTTCggTgACAACACCAAggCggC-3P (nt 646^
678) and antisense 5P-CgAgCAAAggCCTCTgCCACCTTgCggTT-3P
(nt 808^837)] were used for PCR, yielding products of 83, 140, 674,
531, 151, 228, 510, 197, and 191 bp, respectively.
3. Results and discussion
3.1. Derivation of cell lines E-1 and E-2
Three ICMs were isolated by microsurgery from frozen and
thawed equine blastocysts. They were plated on a feeder layer
of bovine umbilical cord ¢broblasts and they began to spread
out after 3^5 days in culture (Fig. 1A). Two of the three ICMs
grew as individual colonies composed of tightly packed com-
pact cells. The growing colonies were mechanically dislodged
from outer £attened cells and treated with trypsin to dissoci-
ate cells. After replating, these dissociated cells formed com-
pact colonies of small cells, as commonly observed in the case
of murine ES cells (Fig. 1B) [25]. We established two lines of
ES-like cells, E-1 and E-2, and these cells had a diploid XY
karyotype (62+XY) [29] up to the 15th^20th and 11th^15th
passages, respectively (Fig. 1C). The results were con¢rmed by
sexing equine ES-like cells with a Y chromosome-speci¢c
DNA probe, namely, sex-determining region Y (SRY) [31],
by PCR (Fig. 1D). The homogeneity in terms of chromosome
number and the diploidy of the cells suggested that these lines
should remain genotypically and phenotypically stable in vitro
for many generations. Both lines of equine ES-like cells were
successfully cryopreserved after any number of passages ex-
amined after 3^8 months of continuous development. Cells
have been successfully thawed without loss of the potential
for proliferation after preservation for more than 12 months
Fig. 1. Characterization of equine ES-like cells. A: ICM after 5 days in culture (E-1 line). B: Colonies of ES-like cells (E-1 line). C: A meta-
phase spread of ES-like cells (E-2 line) that included an X chromosome (arrow) and a Y chromosome (arrowhead). Female and male karyo-
types were identi¢ed by £uorescence in situ hybridization using X chromosome- and Y chromosome-staining probes (gifts from Animal Re-
search Institute, Shirakawa, Fukushima, Japan). D: Ampli¢cation by PCR of sex-determining region Y (SRY) from equine ES-like cells. Lane
1, E-1 line; lane 2, E-2 line; lane 3, E-1 line; lane 4, HeLa cells; lane 6, P19 cells; lane 7, F9 cells; lane 8, E-2 line; lane 9, MCF-7 cells; lane
5, E-1 line without KOD Dash polymerase. Lanes 1, 2, 4, 5, 6, 7, 9, ampli¢cation with combination 1 primer sets for SRY-1; lanes 3 and 8,
ampli¢cation with combination 2 primer sets for SRY-1. M, Molecular markers (HaeIII digest of xX174). E: ES-like cells (E-1 line) under-
going partial di¡erentiation, after culture for 5 days in the absence of a feeder layer of bovine cells but in the presence of LIF (10 ng/ml).
F: EBs, 2 weeks after the start of suspension culture (E-2 line). Magni¢cation: A, B and F, U200; E, U100; C, U600.
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[27,28]. E-1 cells have been cultured for 56 passages in vitro
and E-2 cells have been cultured for 38 passages. Strelchenko
et al. [32] reported a limit of approximately 60 divisions for
most non-immortalized cells. Therefore, we can distinguish
immortalized cell lines from non-immortalized cell lines on
the basis of the ability of cells to undergo more than 60
divisions. Since our lines of equine ES-like cells have divided
a minimum of 392 and 266 times, respectively, these cells
appear to be immortal and to remain in an undi¡erentiated
state inde¢nitely in vitro. By contrast to murine ES cells,
equine ES-like cells di¡erentiated to epithelial-like cells in
the absence of a feeder layer, provided the medium was sup-
plemented with LIF (Fig. 1E). When equine ES-like cells were
cultured as large clumps of cells (more than 100 cells per
aggregate) in the absence of a feeder layer, they multiplied
rapidly for several days after transfer to fresh medium and
formed tight aggregates that increased in size with time in
culture. When such cultures were maintained for 2^4 weeks,
the cell aggregates developed into cystic EBs (Fig. 1F). These
cystic EBs were composed of two layers of cells with hetero-
geneous cellular particles within the cavity (Fig. 1F, see largest
EB). Endoderm-like cells were located on the external surface
of the cystic EBs and ectoderm-like cells were located on the
internal surface. The phenotype of equine EBs resembled that
of mouse and bovine EBs [13,25]. The cells of equine EBs
were able to di¡erentiate into epithelial, ¢broblastic and neu-
ron-like cells when re-attached to the surface of a dish (data
not shown). Thus, the equine ES-like cells seemed to be
strictly dependent on a feeder layer for maintenance of an
undi¡erentiated state.
3.2. Expression of markers by equine ES-like cells
We examined the two lines of ES-like cells for the expres-
sion of markers that indicate an undi¡erentiated state. We
Fig. 2. Expression of molecular markers of undi¡erentiated equine ES-like cells. A: Alkaline phosphatase, as visualized by the method of Tal-
bot et al. ([26]; E-2 line). B: Flow-cytometric pro¢les of cells (E-1 line) after immunostaining with antibodies against SSEA-1 (indicated in
blue) and with equine IgG (indicated in green). Close to 40% of cells were immunopositive for SSEA-1. C: Immunostaining of ES-like cells
with STAT-3-speci¢c antibody (E-1 line). D: Analysis of the expression of genes for Oct 4, STAT-3 and GAPDH by RT-PCR (E-1 line). Total
RNA was extracted from equine ES-like cells (E-1 line) that had been cultured on a feeder layer (lanes 2) and in the presence of LIF (lane 1)
and in the absence of both LIF and a feeder layer (lane 3). Magni¢cation: A and C, U100.
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Fig. 3. Morphological di¡erentiation and expression of markers by ES-like cell-derived neural precursors. ES-like cells were cultured in serum-
free KMEM plus 10% FBS with bFGF, EGF and PDGF for 7 days and then analyzed for markers of neural precursor cells. A: Immunostain-
ing with the nestin-speci¢c antibody. B: Immunostaining with antibody against the astrocyte-speci¢c antigen GFAP. C: Immunostaining with
antibody against the neuron-speci¢c antigen L-tubulin III. D: Phase contrast micrograph showing the extensive outgrowth of neural structures
from ES-like cells. Magni¢cation: A^D, U200. E: Analysis of the expression of marker genes in equine ES cell-derived neural precursors. Total
RNA from ES-like cells (lane 1) and from ES-like cells that had been treated with bFGF, EGF and PDGF for 4 days (dES; lane 2) and 7 days
(dES; lane 3) was analyzed by RT-PCR for the expression of genes for GFAP, L-tubulin III and GAPDH.
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detected tissue-non-speci¢c alkaline phosphatase activity [26]
in both lines of equine ES-like cells (Fig. 2A). Such activity
has been demonstrated in pluripotent stem cells of mouse [25]
and human [5,6] origin, as well as in stem-like cells of sheep
[10] and pig [10], but not in bovine stem-like cells [13]. The
equine ES-like cells expressed the cell surface marker SSEA-1,
which is characteristic of undi¡erentiated mouse ES cells [25].
Fluorescence-activated cell sorting (FACS) analysis indicated
that close to 40% of our equine ES-like cells were strongly
positive for immunostaining with an antibody raised against
mouse SSEA-1 (Fig. 2B). The equine ES-like cells di¡ered
from human stem cells, which do not express SSEA-1 but
do express SSEA-3 and SSEA-4 [5,6]. The equine ES-like cells
did not express either SSEA-3 or SSEA-4 (data not shown).
Equine ES-like cells expressed the STAT-3 antigen (Fig.
2C) [23]. We examined the expression of STAT-3 in undi¡er-
entiated and di¡erentiated equine ES-like cells, in the absence
of a feeder layer and in medium without LIF, by RT-PCR.
We detected an ampli¢ed DNA fragment of 531 bp in the
analysis of RNA from undi¡erentiated equine ES-like cells
but not from di¡erentiated ES-like cells (upper panel in Fig.
2D). This fragment was of the size expected for the cDNA of
STAT-3, which is a transcription factor that plays a central
role in the maintenance of the pluripotent phenotype of mu-
rine ES cells [23]. A reduction in the level of active STAT-3
caused by withdrawal of or reduction in the level of LIF is
detrimental to the self-renewal of mouse ES cells because the
inhibition by LIF of di¡erentiation-signaling pathways in ES
cells involves STAT-3 [23].
It has been demonstrated that Oct 4, a protein that is
primarily expressed in pluripotent lineages and is regarded
as having a role in the development of germ cells [24,33,
34], is widely expressed in early embryos. Therefore, we exam-
ined the expression of Oct 4 in undi¡erentiated and dif-
ferentiated equine ES-like cells and con¢rmed the expres-
sion of Oct 4 in undi¡erentiated ES-like cells by RT-PCR,
detecting an ampli¢ed DNA fragment of 674 bp that was
derived from RNA from undi¡erentiated equine ES-like
cells but not from di¡erentiated ES-like cells (upper panel in
Fig. 2D). Thus, Oct 4 was expressed in our equine ES-like
cells, as it is in human ES cells [6]. Maintenance of murine ES
cells in an undi¡erentiated state requires the cooperative
actions of Oct 4 and STAT-3. Thus, Oct 4 and STAT-3
are essential for maintenance of the stem cell phenotype, in
conjunction with activation of the LIF signaling pathway
[23,24,33].
The feeder layer that is required to support the serial culti-
vation of mouse ES cells can be replaced by LIF. However,
such was not the case for equine ES-like cells in the undi¡er-
entiated state. We noted that the morphology of equine ES-
like cells in the undi¡erentiated state resembled that of murine
ES cells. However, the presence of LIF was not required for
maintenance of equine ES-like cells in an undi¡erentiated
state. By contrast, cultivation of ES-like cells on a feeder layer
was necessary to maintain equine ES-like cells in an undif-
ferentiated state. Such di¡erences between the two systems
and the signals that maintain equine ES-like cells in an un-
di¡erentiated state remain to be clari¢ed. In contrast to
murine ES cells, human ES cells do not rely on LIF for inhi-
bition of di¡erentiation [5,6], and we found the same to be
true for our equine ES-like cells. The markers, mentioned
above, that are characteristic of ES cells should be useful
for the selection of clonal ES or ES-like cells from other
mammals.
3.3. Di¡erentiation of neural precursor cells from equine
ES-like cells in vitro
Interest in the therapeutic potential of ES cells has been
stimulated by the ¢nding that human ES cells can serve as a
source of precursors to neural cells [5,6]. To examine the
ability of equine ES-like cells to di¡erentiate to neural pre-
cursor cells, we cultured ES-like cells in a de¢ned medium that
contained a mixture of growth factors. After 7 days in culture,
equine ES-like cells developed into bipolar ¢brous cells that
were immunopositive for nestin (Fig. 3A) [30]. Upon removal
of growth factors, the bipolar ¢brous cells di¡erentiated to
astrocytes or neurons within 7^14 days, becoming immuno-
positive for the astrocyte-speci¢c marker GFAP (Fig. 3B) [30].
Some cells also expressed the neuron-speci¢c marker L-tubulin
III (Fig. 3C) [30] and had an obviously neural morphology
with the extensive outgrowth of ¢bers (Fig. 3D). We per-
formed RT-PCR to examine the transcripts of the genes for
GFAP and L-tubulin III and detected the expression of these
genes in the neurally di¡erentiated ES-like cells (Fig. 3E). In
the present study, we developed a new method for induction
of the di¡erentiation of neural precursors from ES-like cells,
using a combination of bFGF, EGF and PDGF. Our method
does not involve treatment with retinoic acid [30], formation
of EBs [6,30] or feeder layer-derived induction activity [35].
Our results are in harmony with the observations that neural
stem cells can be isolated and cultured in vitro from the adult
subventricular zone [36] and other regions of the brain in the
presence of EGF and bFGF [36]. Culture medium containing
bFGF and PDGF promotes the proliferation of glial precur-
sor cells [2]. We used both growth factors together to induce
the di¡erentiation of equine ES-like cells to neural and glial
precursor cells.
3.4. Di¡erentiation of precursors to hematopoietic and
endothelial cells
Murine ES cells that have been induced to di¡erentiate in
vitro can give rise to hematopoietic precursors and endothe-
lium in the presence [3,4] and in the absence [37] of the for-
mation of EBs. To examine the ability of equine ES-like cells
to generate hematopoietic precursors, we incubated ES-like
cells in the presence of bFGF, SCF and OSM [38]. We found
two di¡erent types of cell colony in the same culture wells
after 10 days of culture. One type of colony consisted of
non-adherent, rounded, cobblestone-like cells and the other
consisted of adherent endothelial-like cells (Fig. 4A). Forma-
tion of cobblestone areas is a typical feature of hematopoietic
stem cells [38]. The clusters of cobblestone cells were immuno-
positive for CD45 [37,38], a marker of hematopoietic progen-
itor cells (Fig. 4B). By contrast, endothelial-like cells were
only minimally immunopositive (Fig. 4B). After a further 7^
10 days in culture, adherent cells cultured in the absence of
growth factors were positive for immunostaining with various
markers of endothelial cells, namely, Flk-1 [37], CD31 and
CD34 (Fig. 4C^E) [37,38]. We used RT-PCR to detect tran-
scripts of genes for GATA-4 and Flk-1 and con¢rmed the
expression of these genes in the ES cell-derived hematopoietic
precursor cells (Fig. 4F) [37,38].
The ES cells that were proliferating in two dimensions were
able to di¡erentiate to hematopoietic cells and, thus, it ap-
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peared that neither a three-dimensional EB structure nor a
layer of feeder cells was required for this process, as was
also the case for the di¡erentiation of equine ES-like cells to
neural precursor cells.
In this study, we demonstrated that immortalized pluripo-
tent equine ES-like cells can be induced to generate both
neural and hematopoietic cells in vitro. However, here we
cannot report the chimerism of equine ES-like cells and their
germline transmission. The production of chimeric equines
with traits that are transmitted through the germ line is now
being undertaken to con¢rm the competence of totipotency
and pluripotency of the ES cells.
Equine ES-like cells should be useful as an unlimited and
valuable source of cells for gene targeting and the generation
of transgenic clonal o¡spring and also as a powerful tool for
studies of the mechanisms of activation of growth factors.
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Fig. 4. Morphological di¡erentiation and expression of markers by ES-like cell-derived hematopoietic precursors. ES-like cells were cultured in
KMEM plus 10% FBS, SCF, bFGF and OSM for 10 days. A: Phase contrast micrograph of cobblestone-like cells and adherent endothelial-
like cells. B: Immunostaining of the same culture as in A with CD45-speci¢c antibody. Round cobblestone-like cells were immunopositive. ES-
like cells that had di¡erentiated to endothelial precursors were immunostained with antibodies speci¢c for CD31, CD34, and Flk-1, as shown
in panels C, D, and E, respectively. Magni¢cation: A^E, U100. F: Expression of genes for markers of hematopoietic and endothelial di¡eren-
tiation in undi¡erentiated ES-like cells (ES) and di¡erentiated ES-like cells (dES). RNA from ES-like cells (lane 1) and from ES-like cells
treated with SCF, bFGF and OSM for 5 days (lane 2) and 10 days (lane 3) was analyzed by RT-PCR for expression of genes for GATA-4,
Flk-1 and GAPDH.
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